Validation of single‐cell transcriptomic profiles from Illumina and MGI Tech sequencing platforms
FEBS Letters · 2025
DOI: 10.1002/1873-3468.70087 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift FEBS Letters, 2025. Verfasst von Valerie Vandenbempt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Brussels, Belgium. Hauptthemen laut MEDLINE: Single-Cell Analysis, Transcriptome, High-Throughput Nucleotide Sequencing, Gene Expression Profiling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: H2020 European Research Council.
Abstract (Originalsprache)
While Illumina is currently used for high‐throughput short‐read sequencing, MGI Tech have developed a similar sequencing method at a lower cost. Comparisons of the two platforms revealed that their accuracy, sensitivity, and reproducibility are very similar, but the impact of each on biological insights, particularly in heterogeneous samples, remains unknown. Illumina and MGI Tech were used to generate single‐cell RNA‐seq libraries from three human cancer samples. While unique platform‐specific cells arise after additional cell quality controls, the chosen sequencing platform did not affect either clustering or gene expression analyses. In conclusion, MGI Tech delivers transcriptomic profiles similar to those of Illumina and can be confidently used for high‐throughput applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Brussels, Belgium.
- Adelaide Centre for Epigenetics, Australia.
- South Australian ImmunoGENomics Cancer Institute, Adelaide, Australia.
- Faculty of Health and Medical Sciences, The University of Adelaide, Australia.
- Single Cell and Spatial-Omics Laboratory, Adelaide Centre of Epigenetics, University of Adelaide, Australia.
- Department of Anatomy & Developmental Biology, Biomedicine Discovery Institute, Monash University, Australia.
ORCID-Profile: Esteban N Gurzov
Förderung
- H2020 European Research Council
Zitieren
APA
Vandenbempt, V., Roach, M., Mohenska, M., Wise, K., Wang, T., Harvey, K., Jensen, K., Swarbrick, A., Polo, J. M., Gurzov, E. N., & Martelotto, L. G. (2025). Validation of single‐cell transcriptomic profiles from Illumina and MGI Tech sequencing platforms. FEBS Letters. https://doi.org/10.1002/1873-3468.70087
Vancouver
Vandenbempt V, Roach M, Mohenska M, Wise K, Wang T, Harvey K, et al. Validation of single‐cell transcriptomic profiles from Illumina and MGI Tech sequencing platforms. FEBS Letters. 2025. doi:10.1002/1873-3468.70087
BibTeX
@article{Vandenbempt2025,
author = {Vandenbempt, Valerie and Roach, Michael and Mohenska, Monika and Wise, Kellie and Wang, Taopeng and Harvey, Kate and Jensen, Kirk and Swarbrick, Alexander and Polo, Jose M and Gurzov, Esteban N and Martelotto, Luciano G},
title = {Validation of single‐cell transcriptomic profiles from Illumina and MGI Tech sequencing platforms},
journal = {FEBS Letters},
year = {2025},
doi = {10.1002/1873-3468.70087}
}
EUVIMED